Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
11.09
-0.56 (-4.81%)
Oct 16, 2025, 4:00 PM EDT - Market closed
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $49.24 million as of October 17, 2025. Its market cap has increased by 39.53% in one year.
Market Cap
49.24M
Enterprise Value
43.62M
1-Year Change
39.53%
Ranking
Category
Stock Price
$11.09
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $49.24M, a decrease of -44.45%. That is a compound annual growth rate of -12.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 51.73M | 42.03% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |